Combating The Global Medical Challenge Caused By Gram-negative 'superbugs': From Redeveloping The Polymyxins To Discovering Novel Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$375,012.00
Summary
Bacterial �superbugs� are becoming a major global medical challenge. Polymyxins are the last-line antibiotics against Gram-negative �superbugs� but with little pharmacological information available. I am an antimicrobial pharmacologist specialised in re-developing polymyxins, and discovering novel antibiotics against these very troublesome bacteria. My research targets the _Bad Bugs, No Drugs� disaster highlighted by the Infectious Diseases Society of America and the World Health Organization.
I am an immunologist studying the interaction between cancer and the immune system. I am involved in the development and characterization of immunotherapies for cancer.
I am an applied physiologist determining risk factors for falls and strategies for prevention in older people and clinical groups with balance disorders. I pursue this research primarily through epidemiological studies.
I am a cardiovascular clinician-scientist involved in characterising the cellular and molecular pathogenesis of heart failure. My goal is to translate these findings into clinical solutions.